Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 May 23;5(6):ofy123.
doi: 10.1093/ofid/ofy123. eCollection 2018 Jun 1.

The Cefazolin Inoculum Effect Is Associated With Increased Mortality in Methicillin-Susceptible Staphylococcus aureus Bacteremia

Affiliations

The Cefazolin Inoculum Effect Is Associated With Increased Mortality in Methicillin-Susceptible Staphylococcus aureus Bacteremia

William R Miller et al. Open Forum Infect Dis. .

Abstract

Background: Recent studies have favored the use of cefazolin over nafcillin for the treatment of methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia. The clinical influence of the cefazolin inoculum effect (CzIE) in the effectiveness of cephalosporins for severe MSSA infections has not been evaluated.

Methods: We prospectively included patients from 3 Argentinian hospitals with S. aureus bacteremia. Cefazolin minimum inhibitory concentrations (MICs) were determined at standard (105 colony-forming units [CFU]/mL) and high (107 CFU/mL) inoculum. The CzIE was defined as an increase of MIC to ≥16 µg/mL when tested at high inoculum. Whole-genome sequencing was performed in all isolates.

Results: A total of 77 patients, contributing 89 MSSA isolates, were included in the study; 42 patients (54.5%) had isolates with the CzIE. In univariate analysis, patients with MSSA exhibiting the CzIE had increased 30-day mortality (P = .034) and were more likely to have catheter-associated or unknown source of bacteremia (P = .033) compared with patients infected with MSSA isolates without the CzIE. No statistically significant difference between the groups was observed in age, clinical illness severity, place of acquisition (community vs hospital), or presence of endocarditis. The CzIE remained associated with increased 30-day mortality in multivariate analysis (risk ratio, 2.65; 95% confidence interval, 1.10-6.42; P = .03). MSSA genomes displayed a high degree of heterogeneity, and the CzIE was not associated with a specific lineage.

Conclusions: In patients with MSSA bacteremia where cephalosporins are used as firstline therapy, the CzIE was associated with increased 30-day mortality. Clinicians should be cautious when using cefazolin as firstline therapy for these infections.

Keywords: cephalosporins; endocarditis; inoculum effect; methicillin-susceptible Staphylococcus aureus.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Phylogenetic tree of the core genome of 89 Argentinian methicillin-susceptible Staphylococcus aureus isolates and 3 control sequences. The outermost circle denotes the BlaZ type for each β-lactamase; isolates without a β-lactamase are left blank. The outer-middle circle shows the presence (black) or absence (white) of the cefazolin inoculum effect (CzIE) in each isolate. The inner-middle circle lists the sequence type, and the innermost circle lists the name for each isolate; single isolates are colored white, and paired isolates from the same patient are colored gray. The light blue circles at each branch point show the bootstrap support values, varying from 70 to 100.

Similar articles

Cited by

References

    1. Tong SY, Davis JS, Eichenberger E et al. . Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev 2015; 28:603–61. - PMC - PubMed
    1. Cosgrove SE, Sakoulas G, Perencevich EN et al. . Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003; 36:53–9. - PubMed
    1. van Hal SJ, Jensen SO, Vaska VL et al. . Predictors of mortality in Staphylococcus aureus bacteremia. Clin Microbiol Rev 2012; 25:362–86. - PMC - PubMed
    1. Dantes R, Mu Y, Belflower R et al. . National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011. JAMA Intern Med 2013; 173:1970–9. - PMC - PubMed
    1. Hadler JL, Petit S, Mandour M, Cartter ML. Trends in invasive infection with methicillin-resistant Staphylococcus aureus, Connecticut, USA, 2001–2010. Emerg Infect Dis 2012; 18:917–24. - PMC - PubMed

LinkOut - more resources